Related Experiment Videos
[Cell cycle regulation after exposure to ionizing radiation].
F Teyssier1, J O Bay, C Dionet
1Laboratoire de biophysique, Faculté de médecine J.-Lisfranc, 15, rue Ambroise-Paré, 42023 Saint-Etienne Cedex 02.
Bulletin Du Cancer
|May 26, 1999
Summary
Ionizing radiation triggers cell cycle arrest and DNA repair. Targeting cell cycle checkpoints, particularly the G2 checkpoint, shows promise for enhancing cancer therapy effectiveness.
Area of Science:
- Cellular Biology
- Radiation Biology
- Molecular Oncology
Context:
- Ionizing radiation induces DNA damage, initiating cellular responses including cell cycle arrest, apoptosis, and DNA repair.
- Oxidative damage to lipids can also activate signaling pathways involved in apoptosis and cell cycle regulation.
- Understanding the conversion of DNA damage into intracellular signals is crucial for cell cycle control.
Purpose:
- To elucidate the molecular mechanisms by which cells respond to ionizing radiation, focusing on cell cycle regulation.
- To identify key proteins and pathways involved in DNA damage signaling and cell cycle arrest.
- To explore the therapeutic potential of targeting cell cycle checkpoints in cancer treatment.
Summary:
- DNA damage activates proteins like ATM and DNA-PK, which can trigger cell cycle arrest via the p53 tumor suppressor.
- p53 regulates downstream effectors such as p21WAF1/CIP1, a CDK inhibitor, and other inhibitors like p27KIP1 and p15INK4b, contributing to G1 arrest.
- Radiation-induced G2 arrest involves ATM-dependent pathways and phosphorylation of cdc2, while G1 arrest aids in eliminating damaged cells.
Impact:
- Deficiencies in cell cycle regulation, common in cancer, can lead to resistance to ionizing radiation.
- Targeting cell cycle checkpoints, especially the G2 checkpoint, presents a potential strategy for sensitizing cancer cells to radiation therapy.
- Inhibitors of the G2 checkpoint, such as caffeine and protein kinase inhibitors, have shown potential in sensitizing cells to ionizing radiation, though clinical applications are still under investigation.